BioMarin Pharmaceutical Operating Income 2010-2024 | BMRN
- BioMarin Pharmaceutical annual operating income for 2023 was $0.158B, a 5.71% increase from 2022.
- BioMarin Pharmaceutical annual operating income for 2022 was $0.15B, a 281.64% decline from 2021.
- BioMarin Pharmaceutical annual operating income for 2021 was $-0.082B, a 89.55% increase from 2020.